IISc Bangalore 2026 Admissions are now open! Apply for M.Sc, M.Tech, M.Des, M.Mgt, Integrated Ph.D, and Research Programmes. Deadline: March 23, 2026.
This article provides a detailed guide to the top engineering colleges in India in 2026, including leading government ...
The Print on MSN
Genetics, biotechnology, robotics—India’s MoU with Iranian universities are in limbo
A senior professor from Jamia Millia Islamia University told ThePrint that the tenure of most of the university’s partnerships was either over or was on the verge of expiry.
How do we turn the science of aging into trustworthy, deployable systems that improve human lives at meaningful scale?
A biotechnology spin-out company from The University of Manchester has closed a £3m seed funding round led by Northern Gritstone.
Monoclonal antibodies have become one of the most established and clinically successful therapeutic modalities, supported by ...
India Today NE on MSN
AAU Jorhat hosts training on genome engineering to boost agricultural innovation in northeast
A major capacity-building initiative aimed at strengthening agricultural biotechnology research in the Northeast began on Monday at Assam Agricultural University (AAU) in Jorhat, with scientists, ...
Panchkula’s Akansh Dhull, 25, clinched AIR 3 in his third attempt after obtaining AIR 342 in 2023 and AIR 295 in 2024 ...
Innovative glycobiology platform aimed at enhancing the efficacy, safety, and scalability of next-generation antibody therapeutics across multiple disease areas ...
News Medical on MSN
New collaboration aims to accelerate biomedical innovation and education
The Terasaki Institute for Biomedical Innovation (TIBI) and Keck Graduate Institute (KGI) have announced a new collaborative research partnership designed to accelerate biomedical innovation through ...
Oslo, Norway, 09 March 2026 - Zelluna (OSE: ZLNA), a company pioneering allogeneic "off-the-shelf" T Cell Receptor-based Natural Killer (TCR-NK) cell therapies for the treatment of solid cancers, toda ...
Therapeutic developers are increasingly rebuilding their workflows around AI to bring drugs to patients faster.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results